Acremonium strictum

Bailey AM, Cox RJ, Harley K, Lazarus CM, Simpson TJ, Skel-1am E. Characterisation of 3-methylorcinaldehyde synthase (MOS) in Acremonium strictum first observation of a reductive release mechanism during polyketide biosynthesis. Chem. Commun. 2007 4053-4055. 

Ainsworth AM, Chicarelli-Robinson MI, Copp BR, Fauth U, Hylands PJ, Holloway JA, Fatif M, O Beime GB, Porter N, Renno DV, Richards M, Robinson N, Xenovulene A. A novel GABA-benzodiazepine receptor binding compound produced by Acremonium strictum. J Antibiot 48 568-573, 1995. 

Hyphomycetes. Conidia not within cavities. Includes yeasts (Y), sometimes separated as Blastomycetes. Acremonium strictum... 

A major infectious cause of death in HSC transplant recipients is invasive fungal infection (Allan et al. 1988 Bodey and Vartivarian 1989 Bag 2003). Beyond the first week after transplantation, fungal infections become increasingly common, being identified as a cause of pneumonia in 12%-50% of patients (Connolly et al. 1999). With increased use of prophylactic fluconazole, infections with resistant fungi have become more common. Other less common pulmonary mycoses (e.g., Penicillium purpu-rogenum, Acremonium strictum and Scedosporium apiospermum) have been also observed. 

Kontani, M., Sakagami. Y, and Mammo, S. (1994) First p-l,6-glucan biosynthesis inhibitor, bisvertinolone isolated from fungus, Acremonium strictum and its absolute stereochemistry. Tetrahedron Lett., 35,2577-2580. 

---